ABCL - AbCellera Biologics Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$8.00
DETAILS
HIGH:
$9.00
LOW:
$7.00
MEDIAN:
$8.00
CONSENSUS:
$8.00
DOWNSIDE:
13.98%
Profitability Ratios
| Ratio | Value |
|---|---|
| GP Margin | 61.6% |
| EBIT Margin | -236.4% |
| EBITDA Margin | -198.0% |
| Operating Margin | -289.0% |
| Pretax Margin | -236.4% |
| Cont. Ops Margin | -194.9% |
| Net Margin | -194.9% |
| Bottom Line Margin | -194.9% |
Liquidity Ratios
| Ratio | Value |
|---|---|
| Current Ratio | 11.32 |
| Quick Ratio | 11.23 |
| Solvency Ratio | -0.301 |
| Cash Ratio | 2.00 |
Valuation Ratios
| Ratio | Value |
|---|---|
| Price/Earnings |
-6.98
Hist. avg: 56.5
Peer avg not available.
|
| PEG Ratio | 0.64 |
| Forward PEG | 0.64 |
| Price/Book | 1.06 |
| Price/Sales | 13.60 |
| Price/FCF | -5.87 |
| Price/Op Cash Flow | -7.78 |
Debt Ratios
| Ratio | Value |
|---|---|
| Debt/Assets | 0.1055 |
| Debt/Equity | 0.1481 |
| Debt/Capital | 0.1290 |
| Long-Term Debt/Capital | 0.0000 |
| Financial Leverage | 1.40 |
Cash Flow Ratios
| Ratio | Value |
|---|---|
| Working Capital Turnover | 0.11 |
| Operating Cash Flow Ratio | -2.042 |
| Operating Cash Flow/Sales | -174.8% |
| Free Cash Flow/Operating Cash Flow | 132.6% |
Coverage Ratios
| Ratio | Value |
|---|---|
| Debt Service Coverage | 0.00 |
| Interest Coverage | 0.0000 |
| Short-Term Operating Cash Flow Coverage | 0.00 |
| Operating Cash Flow Coverage | -0.92 |
| Capital Expenditure Coverage | -3.07 |
| Dividend + Capital Expenditure Coverage | -3.07 |
Dividend Ratios
| Ratio | Value |
|---|---|
| Payout Ratio | 0.0000% |
| Dividend Yield | 0.0000% |
| Dividend Yield % | 0.0000% |
| Dividend Per Share | 0.0000 |
Per Share Ratios
| Ratio | Value |
|---|---|
| Revenue/Share | 0.25 |
| EPS | -0.490 |
| Debt/Share | 0.4795 |
| Cash/Share | 1.79 |
| Book Value/Share | 3.24 |
| Tangible BV/Share | 2.95 |
| Equity/Share | 3.24 |
| Operating Cash Flow/Share | -0.440 |
| Capital Expenditure/Share | 0.143 |
| FCF/Share | -0.583 |
Other Ratios
| Ratio | Value |
|---|---|
| Net Income/Earnings Before Tax | 0.824 |
| Earnings Before Tax/EBIT | 0.818 |
| Price/Fair Value | 1.06 |
| Debt/Market Cap | 0.0000 |
| Effective Tax Rate | 17.6% |
| Enterprise Value Multiple | -6.97 |